3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Sarcoma
1
Rectal Neoplasms
1
Plasmacytoma
1
Pancreatic Neoplasms
1
Neoplasm Metastasis
1
Margins of Excision
1
Homologous Recombination Deficient Solid Tumors
1
Drug-Related Side Effects and Adverse Reactions
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Interventions
Lenalidomide
3
Dexamethasone
3
ixazomib
2
dexamethasone acetate
2
dexamethasone 21-phosphate
2
auricularum
2
Radiotherapy
2
Calcium Dobesilate
2
pomalidomide
1
daratumumab
1
cc-486
1
Thalidomide
1
Sodium Selenite
1
Radiation
1
Peripheral Blood Stem Cell Transplantation
1
Panobinostat
1
Melphalan
1
Immunotherapy, Adoptive
1
Gemcitabine
1
Drug Combinations
1
Busulfan
1
Bortezomib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Plasmacytoma
×
Drug Combinations
×
Clear all
NCT04065308
2019-08-22
Dara_DCEP
Seoul National University Hospital
Phase 2
Unknown
33 enrolled